KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Hims & Hers Health (HIMS) Equity Average (2019 - 2025)

Historic Equity Average for Hims & Hers Health (HIMS) over the last 7 years, with Q3 2025 value amounting to $571.8 million.

  • Hims & Hers Health's Equity Average rose 4260.02% to $571.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $571.8 million, marking a year-over-year increase of 4260.02%. This contributed to the annual value of $410.4 million for FY2024, which is 2515.74% up from last year.
  • Per Hims & Hers Health's latest filing, its Equity Average stood at $571.8 million for Q3 2025, which was up 4260.02% from $556.0 million recorded in Q2 2025.
  • Hims & Hers Health's 5-year Equity Average high stood at $571.8 million for Q3 2025, and its period low was $72.8 million during Q1 2021.
  • Its 5-year average for Equity Average is $358.0 million, with a median of $331.2 million in 2022.
  • Its Equity Average has fluctuated over the past 5 years, first soared by 638206.48% in 2021, then tumbled by 972.57% in 2022.
  • Quarter analysis of 5 years shows Hims & Hers Health's Equity Average stood at $344.9 million in 2021, then decreased by 9.73% to $311.3 million in 2022, then increased by 8.01% to $336.3 million in 2023, then skyrocketed by 36.3% to $458.4 million in 2024, then rose by 24.75% to $571.8 million in 2025.
  • Its Equity Average was $571.8 million in Q3 2025, compared to $556.0 million in Q2 2025 and $513.0 million in Q1 2025.